DaVita Inc. (NYSE:DVA) Receives $162.80 Consensus Target Price from Analysts

Shares of DaVita Inc. (NYSE:DVA - Get Free Report) have been assigned a consensus rating of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $162.80.

Separately, Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday.

Hedge Funds Weigh In On DaVita

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mackenzie Financial Corp lifted its stake in DaVita by 116.5% in the fourth quarter. Mackenzie Financial Corp now owns 7,931 shares of the company's stock valued at $1,186,000 after buying an additional 4,267 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of DaVita during the fourth quarter worth $172,000. Neo Ivy Capital Management lifted its holdings in shares of DaVita by 191.1% during the fourth quarter. Neo Ivy Capital Management now owns 12,879 shares of the company's stock worth $1,926,000 after purchasing an additional 8,455 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in DaVita by 14.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock valued at $69,697,000 after acquiring an additional 57,386 shares during the period. Finally, Worldquant Millennium Advisors LLC lifted its holdings in DaVita by 154.4% in the fourth quarter. Worldquant Millennium Advisors LLC now owns 95,372 shares of the company's stock valued at $14,263,000 after acquiring an additional 57,883 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Trading Down 2.5 %

DVA traded down $3.59 on Tuesday, hitting $142.33. The company had a trading volume of 1,605,084 shares, compared to its average volume of 845,867. The firm has a market cap of $11.39 billion, a P/E ratio of 13.25, a PEG ratio of 1.14 and a beta of 0.94. DaVita has a 1 year low of $120.78 and a 1 year high of $179.60. The company's fifty day moving average price is $161.03 and its 200 day moving average price is $157.86. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts expect that DaVita will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.